Manuela Di Fusco

1.6k total citations
58 papers, 751 citations indexed

About

Manuela Di Fusco is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Health. According to data from OpenAlex, Manuela Di Fusco has authored 58 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 21 papers in Infectious Diseases and 13 papers in Health. Recurrent topics in Manuela Di Fusco's work include Atrial Fibrillation Management and Outcomes (26 papers), Cardiac Arrhythmias and Treatments (15 papers) and SARS-CoV-2 and COVID-19 Research (14 papers). Manuela Di Fusco is often cited by papers focused on Atrial Fibrillation Management and Outcomes (26 papers), Cardiac Arrhythmias and Treatments (15 papers) and SARS-CoV-2 and COVID-19 Research (14 papers). Manuela Di Fusco collaborates with scholars based in United States, United Kingdom and Denmark. Manuela Di Fusco's co-authors include Jennifer L. Nguyen, Mary M. Moran, Deepa Malhotra, Jay Lin, Allison Keshishian, Frederick J. Angulo, Amol D. Dhamane, Jack Mardekian, Birol Emir and Hüseyin Yüce and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Manuela Di Fusco

57 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuela Di Fusco United States 15 281 261 123 118 114 58 751
Jawad Ahmed Pakistan 15 249 0.9× 107 0.4× 118 1.0× 38 0.3× 29 0.3× 59 659
Jennifer L. Nguyen United States 14 465 1.7× 79 0.3× 184 1.5× 54 0.5× 123 1.1× 51 847
Lorenzo Cerruti Italy 6 606 2.2× 30 0.1× 260 2.1× 44 0.4× 122 1.1× 9 786
Albert Ariza Spain 8 206 0.7× 135 0.5× 122 1.0× 51 0.4× 50 0.4× 21 658
Sam Hollings United Kingdom 5 189 0.7× 121 0.5× 64 0.5× 36 0.3× 28 0.2× 6 600
Chris Roebuck United Kingdom 5 203 0.7× 161 0.6× 59 0.5× 44 0.4× 21 0.2× 6 670
Enrico G. Ferro United States 14 184 0.7× 174 0.7× 13 0.1× 78 0.7× 10 0.1× 43 708
Bérangère Baricault France 12 227 0.8× 81 0.3× 73 0.6× 13 0.1× 42 0.4× 23 409
Toshio Fukuoka Japan 16 241 0.9× 54 0.2× 128 1.0× 19 0.2× 11 0.1× 48 772
Melissa Lingohr-Smith United States 17 88 0.3× 377 1.4× 25 0.2× 117 1.0× 17 0.1× 74 803

Countries citing papers authored by Manuela Di Fusco

Since Specialization
Citations

This map shows the geographic impact of Manuela Di Fusco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Di Fusco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Di Fusco more than expected).

Fields of papers citing papers by Manuela Di Fusco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Di Fusco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Di Fusco. The network helps show where Manuela Di Fusco may publish in the future.

Co-authorship network of co-authors of Manuela Di Fusco

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Di Fusco. A scholar is included among the top collaborators of Manuela Di Fusco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Di Fusco. Manuela Di Fusco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spaziante, Martina, Sara Leone, Gabriella De Carli, et al.. (2025). Interrupted time series analysis to evaluate the impact of COVID-19-pandemic on the incidence of notifiable infectious diseases in the Lazio region, Italy. BMC Public Health. 25(1). 132–132. 1 indexed citations
2.
Sevilla, J.P., et al.. (2024). The global health and economic value of COVID-19 vaccination. BMJ Global Health. 9(9). e015031–e015031. 1 indexed citations
3.
Malhotra, Deepa, Manuela Di Fusco, Kathleen M. Andersen, et al.. (2024). Economic burden of COVID-19 for employers and employees in the United States. Journal of Medical Economics. 27(1). 267–278. 7 indexed citations
4.
5.
6.
Scott, Amie, Wajeeha Ansari, Farid Khan, et al.. (2024). Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19. BMC Medicine. 22(1). 46–46. 12 indexed citations
7.
Fusco, Manuela Di, Jingyan Yang, Santiago M. C. Lopez, et al.. (2023). The impact of vaccination and outpatient treatment on the economic burden of Covid-19 in the United States omicron era: a systematic literature review. Journal of Medical Economics. 26(1). 1519–1531. 7 indexed citations
8.
9.
Atwater, Brett D., Manuela Di Fusco, Allison Keshishian, et al.. (2023). Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation. Journal of Thrombosis and Thrombolysis. 56(4). 626–634. 5 indexed citations
10.
11.
Fusco, Manuela Di, Diana Mendes, Lotte Steuten, et al.. (2023). The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study. Vaccines. 11(2). 234–234. 7 indexed citations
12.
McGrath, Leah J., Mary M. Moran, Tamuno Alfred, et al.. (2023). Clinical outcomes of COVID-19 and influenza in hospitalized children <5 years in the US. Frontiers in Pediatrics. 11. 1261046–1261046. 4 indexed citations
13.
Fusco, Manuela Di, Xiaowu Sun, Mary M. Moran, et al.. (2023). Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron. Journal of Patient-Reported Outcomes. 7(1). 77–77. 20 indexed citations
14.
Mendes, Diana, et al.. (2022). Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert Review of Vaccines. 22(1). 90–103. 9 indexed citations
15.
Dhamane, Amol D., Mauricio Ferri, Allison Keshishian, et al.. (2022). Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity. Advances in Therapy. 40(3). 887–902. 7 indexed citations
16.
Mendes, Diana, Jessica E. Atwell, Jennifer L. Nguyen, et al.. (2022). Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021. Journal of Medical Economics. 25(1). 1039–1050. 5 indexed citations
17.
Yang, Jingyan, Benjamin Yarnoff, Manuela Di Fusco, et al.. (2022). Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert Review of Vaccines. 22(1). 54–65. 17 indexed citations
18.
Deitelzweig, Steven, Amiee Kang, Cristina Russ, et al.. (2021). EFFECTIVENESS AND SAFETY OF APIXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ENROLLED IN MEDICARE AND VETERAN AFFAIRS. Journal of the American College of Cardiology. 77(18). 1593–1593. 1 indexed citations
19.
Deitelzweig, Steven, Allison Keshishian, Amiee Kang, et al.. (2019). EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS. Journal of the American College of Cardiology. 73(9). 435–435. 1 indexed citations
20.
Morfín‐Otero, Rayo, Martha Alvarado‐Ibarra, Eduardo Rodríguez-Noriega, et al.. (2018). Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico. ClinicoEconomics and Outcomes Research. Volume 10. 511–520. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jawad Ahmed Breakdown of academic impact, for papers by Jennifer L. Nguyen Breakdown of academic impact, for papers by Lorenzo Cerruti Breakdown of academic impact, for papers by Albert Ariza Breakdown of academic impact, for papers by Sam Hollings Breakdown of academic impact, for papers by Chris Roebuck Breakdown of academic impact, for papers by Enrico G. Ferro Breakdown of academic impact, for papers by Bérangère Baricault Breakdown of academic impact, for papers by Toshio Fukuoka Breakdown of academic impact, for papers by Melissa Lingohr-Smith
Rankless by CCL
2026